Matches in DBpedia 2014 for { ?s ?p Telcagepant (formerly MK-0974) was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal potency to rizatriptan and zolmitriptan in two Phase III clinical trials. The company has now terminated development of the drug.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Telcagepant abstract "Telcagepant (formerly MK-0974) was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal potency to rizatriptan and zolmitriptan in two Phase III clinical trials. The company has now terminated development of the drug.".
- Telcagepant comment "Telcagepant (formerly MK-0974) was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal potency to rizatriptan and zolmitriptan in two Phase III clinical trials. The company has now terminated development of the drug.".